Chatham Capital Group, Inc. Anika Therapeutics, Inc. Transaction History

Chatham Capital Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$20.4 - $25.53 $612 - $765	30 Added 0.13%	23,787 $531,000
Q1 2022 Apr 21, 2022	BUY	$24.7 - $36.54 $7,681 - $11,363	311 Added 1.33%	23,757 $597,000
Q4 2021 Feb 02, 2022	BUY	$35.83 - $45.03 $1,254 - $1,576	35 Added 0.15%	23,446 $840,000
Q3 2021 Oct 13, 2021	BUY	$38.75 - $44.47 $25,730 - $29,528	664 Added 2.92%	23,411 $997,000
Q2 2021 Jul 28, 2021	BUY	$39.42 - $48.08 $78 - $96	2 Added 0.01%	22,747 $985,000
Q1 2021 Apr 29, 2021	BUY	$32.49 - $45.96 $738,985 - $1.05 Million	22,745 New	22,745 $928,000

123

11.5M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Chatham Capital Group, Inc. with notifications on news.